|Brand names||Deprefax, Dutonin, Serzone and many others|
Nefazodone is a serotonin antagonist and reuptake inhibitor (SARI) that has been withdrawn from the market in many developed countries (including Australia, Canada, Germany, Italy, New Zealand, Spain, the U.K., etc.), although it is still marketed in Greece and the U.S.A. On top of its SARI activity it also serves as a noradrenaline reuptake inhibitor.
- NCBI Bookshelf provides free book resources on this topic.
- PubMed provides review articles from the past five years (limit to free review articles or to systematic reviews)
- The TRIP database provides clinical publications about evidence-based medicine.
|Antidepressants (ATC: N06A)|